Amidst the rising cases of coronavirus in India we are facing the issue of vaccination failure. People are now afraid to have the vaccination because of some failures and asking questions about its effectiveness.
Healthwire has talked to Dr. Sanket Jain, MD, Pul Med from Masina Hospital regarding the false RT-PCR reports and vaccination efficacy.
What is your experience of treating covid patients?
With over a year of this pandemic and treating over thousands of cases, the experience I want to share is that each patient has a different set of complaints and each person reacts differently according to their immune system.
How much research, studies, or effort it takes to prepare a vaccine?
A vaccine usually takes more than 10 years to develop but it is a proud moment for India to develop such an effective vaccine in a short span of time.
What can be the reason for the ineffectiveness of the vaccine that people are getting infected even after getting the second dose?
Vaccines don’t work instantly. It takes a few weeks for a body to build up immunity after receiving a dose. They require a second shot a few weeks after the first to reach full effectiveness.
Vaccines do not work retroactively, the vaccines prevent illness, But maybe not infection.
Some people are getting negative reports even after showing classic symptoms. What can be the reason?
The RT-PCR has only 70% sensitivity due to some human errors while collecting and processing the sample. The test result could be negative. With the second wave setting in, the virus has mutated and the new strains which are now seen have the ability to invade the lungs directly.
Is there any recommended precaution after vaccination?
Avoid going to crowded places, wear a mask, regular washing of hands and cough etiquette to be maintained even after vaccination.
Is it possible that this vaccine will not be effective for Covid strain at all because after all it was made out of the research of the first wave of Covid-19?
Very little is known about the new covid strain and the efficacy of the vaccine on this strain. More studies and research are needed to come to a conclusion.
